End-of-life care is an essential part of patient-and familycentered care. Yet the experience of dying is frequently marred by insufficient relief of symptoms, burdensome transitions between clinicians and care settings, and distress for family members and caregivers. 1 In the setting of incurable progressive or terminal illness, where death can be considered a predictable event, medical assistance in dying (MAID) has emerged as an option for end-oflife care to address these issues. 2 Specifically, MAID is an option for people with incurable illness who have intolerable suffering or a short prognosis. While the exact definition varies across jurisdictions, MAID can include either euthanasia (ending a patient's life by active drug administration) or physician-assisted suicide (providing drugs for a patient to end their own life) or both. 3 Access to legalized MAID has expanded substantially in the 21st century and is now available to nearly 300 million people worldwide. 3 Accordingly, there are growing debates about access, equity, and appropriateness of MAID across different types of underlying illness. 4 In JAMA Internal Medicine, Heidinger et al 5 analyzed available data from 20 jurisdictions with legalized MAID. Between 1985 and 2023, MAID accounted for 1.4% of all deaths across the 20 jurisdictions and less than 0.5% of deaths within the 9 US states included. Rates of MAID were found to be highest in